Skip to content

Aurinia Pharmaceuticals AUPH Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin89.7%+1.5pp88.5%+0.5pp88.9%+1.7pp89.5%+3.4pp88.2%-0.5pp
Operating margin41.7%+29.4pp37.1%+39.1pp26.3%+41.2pp20%+49.3pp12.3%+51.7pp
Net margin100%+83.9pp101.5%+99.0pp29.3%+39.5pp23.3%+47.6pp16.1%+48.8pp
Returns
Return on equity65%+53.8pp59.9%+58.4pp20.7%+26.4pp17.3%+30.6pp11.2%+27.9pp
Return on invested capital25.2%+17.3pp21.4%+22.5pp16.7%+23.9pp12.8%+27.0pp7.9%+29.2pp
Efficiency
Asset turnover0.5×0.0×0.4×0.0×0.5×+0.1×0.5×+0.1×0.5×+0.1×
Liquidity
Current ratio5.5×-0.4×5.2×+0.7×5.8×+0.2×5.2×-0.1×5.9×+0.3×
Leverage
Debt-to-equity0.2×-0.1×0.2×-0.1×0.3×0.0×0.3×0.0×0.3×0.0×
Net debt / EBITDA0.3×-0.2×0.1×-0.6×0.2×0.6×0.5×
Per Share
Book value per share$4.12+68.6%$4.19+62.3%$2.69+1.0%$2.44-3.6%$2.45-2.0%
Valuation
Market capitalization$1.97B+78.5%$2.1B+63.6%$1.45B+38.7%$1.09B+33.2%$1.1B+54.1%
Price / earnings6.6×-21.1×7.3×-216×18.7×17.9×27.7×
Price / sales6.6×+2.1×7.4×+2.0×5.5×+0.7×4.2×+0.2×4.5×+0.7×
Price / book3.5×+0.3×3.6×+0.2×+1.3×3.2×+1.0×3.2×+1.2×
EV / EBITDA14×-8.7×17×-70.8×16.5×15.8×22.7×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Aurinia Pharmaceuticals's profit margins?
Aurinia Pharmaceuticals (AUPH) runs a 89.7% gross margin and a 41.7% operating margin, with a 100.0% net margin.
Where do Aurinia Pharmaceuticals's ratios come from?
Every ratio is computed from Aurinia Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.